Literature DB >> 11353642

Expression of multidrug efflux pump SmeDEF by clinical isolates of Stenotrophomonas maltophilia.

A Alonso1, J L Martinez.   

Abstract

The presence of the multidrug efflux pump SmeDEF was assessed in a collection of clinical isolates of Stenotrophomonas maltophilia. All isolates encoded this pump, as demonstrated by PCR. Forty-seven percent of the strains overproduced a protein of the same size that was immunoreactive against an anti-SmeF antibody, and 33% overexpressed the gene semD when they were tested by reverse transcription-PCR. A correlation between smeDEF overexpression and antibiotic resistance was observed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11353642      PMCID: PMC90562          DOI: 10.1128/AAC.45.6.1879-1881.2001

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  14 in total

1.  Stenotrophomonas maltophilia D457R contains a cluster of genes from gram-positive bacteria involved in antibiotic and heavy metal resistance.

Authors:  A Alonso; P Sanchez; J L Martínez
Journal:  Antimicrob Agents Chemother       Date:  2000-07       Impact factor: 5.191

2.  Multiple antibiotic resistance in Stenotrophomonas maltophilia: involvement of a multidrug efflux system.

Authors:  L Zhang; X Z Li; K Poole
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

3.  Evidence that TolC is required for functioning of the Mar/AcrAB efflux pump of Escherichia coli.

Authors:  J A Fralick
Journal:  J Bacteriol       Date:  1996-10       Impact factor: 3.490

Review 4.  Evolutionary origins of multidrug and drug-specific efflux pumps in bacteria.

Authors:  M H Saier; I T Paulsen; M K Sliwinski; S S Pao; R A Skurray; H Nikaido
Journal:  FASEB J       Date:  1998-03       Impact factor: 5.191

5.  Characterization of the chromosomal aac(6')-Iz gene of Stenotrophomonas maltophilia.

Authors:  T Lambert; M C Ploy; F Denis; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1999-10       Impact factor: 5.191

6.  Sequence analysis and enzyme kinetics of the L2 serine beta-lactamase from Stenotrophomonas maltophilia.

Authors:  T R Walsh; A P MacGowan; P M Bennett
Journal:  Antimicrob Agents Chemother       Date:  1997-07       Impact factor: 5.191

7.  Sequence analysis of the L1 metallo-beta-lactamase from Xanthomonas maltophilia.

Authors:  T R Walsh; L Hall; S J Assinder; W W Nichols; S J Cartwright; A P MacGowan; P M Bennett
Journal:  Biochim Biophys Acta       Date:  1994-06-21

Review 8.  Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia.

Authors:  M Denton; K G Kerr
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

9.  Cloning and characterization of SmeDEF, a novel multidrug efflux pump from Stenotrophomonas maltophilia.

Authors:  A Alonso; J L Martínez
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191

10.  Biochemical properties of inducible beta-lactamases produced from Xanthomonas maltophilia.

Authors:  R Paton; R S Miles; S G Amyes
Journal:  Antimicrob Agents Chemother       Date:  1994-09       Impact factor: 5.191

View more
  44 in total

1.  Regulatory regions of smeDEF in Stenotrophomonas maltophilia strains expressing different amounts of the multidrug efflux pump SmeDEF.

Authors:  Patricia Sanchez; Ana Alonso; Jose L Martinez
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191

2.  The biocide triclosan selects Stenotrophomonas maltophilia mutants that overproduce the SmeDEF multidrug efflux pump.

Authors:  Patricia Sanchez; Eduardo Moreno; Jose L Martinez
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

3.  Structural and functional analysis of SmeT, the repressor of the Stenotrophomonas maltophilia multidrug efflux pump SmeDEF.

Authors:  Alvaro Hernández; María J Maté; Patricia C Sánchez-Díaz; Antonio Romero; Fernando Rojo; José L Martínez
Journal:  J Biol Chem       Date:  2009-03-26       Impact factor: 5.157

4.  SmQnr contributes to intrinsic resistance to quinolones in Stenotrophomonas maltophilia.

Authors:  María B Sánchez; José L Martínez
Journal:  Antimicrob Agents Chemother       Date:  2009-10-19       Impact factor: 5.191

Review 5.  The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria.

Authors:  Xian-Zhi Li; Patrick Plésiat; Hiroshi Nikaido
Journal:  Clin Microbiol Rev       Date:  2015-04       Impact factor: 26.132

Review 6.  Stenotrophomonas maltophilia: Significant contemporary hospital pathogen - review.

Authors:  O Nyc; J Matejková
Journal:  Folia Microbiol (Praha)       Date:  2010-06-06       Impact factor: 2.099

7.  The efflux pump SmeDEF contributes to trimethoprim-sulfamethoxazole resistance in Stenotrophomonas maltophilia.

Authors:  María Blanca Sánchez; José Luis Martínez
Journal:  Antimicrob Agents Chemother       Date:  2015-04-27       Impact factor: 5.191

8.  Whole-genome sequencing identifies emergence of a quinolone resistance mutation in a case of Stenotrophomonas maltophilia bacteremia.

Authors:  Theodore R Pak; Deena R Altman; Oliver Attie; Robert Sebra; Camille L Hamula; Martha Lewis; Gintaras Deikus; Leah C Newman; Gang Fang; Jonathan Hand; Gopi Patel; Fran Wallach; Eric E Schadt; Shirish Huprikar; Harm van Bakel; Andrew Kasarskis; Ali Bashir
Journal:  Antimicrob Agents Chemother       Date:  2015-08-31       Impact factor: 5.191

9.  Polymorphic mutation frequencies of clinical and environmental Stenotrophomonas maltophilia populations.

Authors:  María Carmen Turrientes; María Rosario Baquero; María Blanca Sánchez; Sylvia Valdezate; Esther Escudero; Gabrielle Berg; Rafael Cantón; Fernando Baquero; Juan Carlos Galán; José Luis Martínez
Journal:  Appl Environ Microbiol       Date:  2010-01-22       Impact factor: 4.792

10.  The Inactivation of intrinsic antibiotic resistance determinants widens the mutant selection window for quinolones in Stenotrophomonas maltophilia.

Authors:  Guillermo García-León; María B Sánchez; José L Martínez
Journal:  Antimicrob Agents Chemother       Date:  2012-09-24       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.